PCI术后PAPP-A与再狭窄及瑞舒伐他汀的关系(4)
[20]Aikawa M， Rabkin E，Sugiyama S ， etal1 An HMG- CoA reductase in2hibitor，cerivastatin，suppresses growth of macrophages expressing matrixmetalloproteinases and tissue factor in vivo and in vitro [J ]1Circulation ，2001 ，103 (2) :276-2831.
[21] Macin SM，Perna ER，Farias EF， et al. Atorvastatin has an important acute anti- inflammatory effect in patients with acute coronary syndrome：results of a randomized，double- blind，placebo- controlled study[J]. AmHeart J，2005，149(3)：451- 457.
[22] Miedema MD，Conover CA，Macdonald H， et al. Pregnancy-asso ciatedplasma protein-A elevation in patients with acute coronary syndrome andsubsequent atorvastatin therapy[J]. Am J Cardiol，2008，101(1)：35- 39.
[23]张钊，张金盈等瑞舒伐他汀对无脂代谢紊乱的急性冠脉综合征患者支架植入术后hs-CRP及(PAPP-A)的影响 中国现代医生52009年3月第47卷第9期.
[24]NegreAminouP，vanVlietAK，van，Erckm，et al，InhibitionofProliferationof smoothmuseleeellsbyvariousHMG一CoAreduetaseinhibiters:eomParisonwit hothereelltypes.BioehimBiophsAeta，1997，1345(3):259一268.
[25]ErlW.Statin-induced vaseularsmoothmuseleeellaPoPtosis:aPossiblerolein thepreventionofrestenosis.CurrDrugTargetsCardiovaseHaematolDisord，2005，5(2):135一144.
[26] Patterson KI，Brummer T，O’Brien PM， et al.Dual-specificity phosphatases: critical regulators with diverse cellular targets.
[27]李芳，余素琴，杜艳华.急性冠脉综合征的炎症机制.内科急危重症杂志，2007,13:133., 百拇医药(赵细英 雷长城)
[21] Macin SM，Perna ER，Farias EF， et al. Atorvastatin has an important acute anti- inflammatory effect in patients with acute coronary syndrome：results of a randomized，double- blind，placebo- controlled study[J]. AmHeart J，2005，149(3)：451- 457.
[22] Miedema MD，Conover CA，Macdonald H， et al. Pregnancy-asso ciatedplasma protein-A elevation in patients with acute coronary syndrome andsubsequent atorvastatin therapy[J]. Am J Cardiol，2008，101(1)：35- 39.
[23]张钊，张金盈等瑞舒伐他汀对无脂代谢紊乱的急性冠脉综合征患者支架植入术后hs-CRP及(PAPP-A)的影响 中国现代医生52009年3月第47卷第9期.
[24]NegreAminouP，vanVlietAK，van，Erckm，et al，InhibitionofProliferationof smoothmuseleeellsbyvariousHMG一CoAreduetaseinhibiters:eomParisonwit hothereelltypes.BioehimBiophsAeta，1997，1345(3):259一268.
[25]ErlW.Statin-induced vaseularsmoothmuseleeellaPoPtosis:aPossiblerolein thepreventionofrestenosis.CurrDrugTargetsCardiovaseHaematolDisord，2005，5(2):135一144.
[26] Patterson KI，Brummer T，O’Brien PM， et al.Dual-specificity phosphatases: critical regulators with diverse cellular targets.
[27]李芳，余素琴，杜艳华.急性冠脉综合征的炎症机制.内科急危重症杂志，2007,13:133., 百拇医药(赵细英 雷长城)